Effects of propofol and isoflurane on haemodynamics and the inflammatory response in cardiopulmonary bypass surgery

References

• Bernhard M, Schultz K, Hofer S et al. MIF and markers of the inflammatory response following cardiac surgery under extracorporeal circulation. Appl Cardiopulm Pathophysiol 2010; 14: 115–23.
   Google Scholar
• Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005; 3 (2): 129–40.
   PubMedGoogle Scholar
• Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs 2014; 38 (1): 11–8.
   PubMed Web of Science ®Google Scholar
• Warren OJ, Smith AJ, Alexiou C et al. The inflammatory response to cardiopulmonary bypass: part 1—mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23 (2): 223–31.
   PubMed Web of Science ®Google Scholar
• Li S, Price R, Phiroz D, Swan K, Crane TA. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol 2005; 37 (2): 180–8.
   PubMedGoogle Scholar
• Schneemilch CE, Hachenberg T, Ansorge S, Ittenson A, Bank U. Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol 2005; 22 (8): 616–23.
   PubMed Web of Science ®Google Scholar
• Zhou R, Yang Z, Tang X, Tan Y, Wu X, Liu F. Propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines in a rat model of experimental stroke. PLoS One 2013; 8; 9 (12): e82729.
   PubMed Web of Science ®Google Scholar
• Li Volti G, Basile F, Murabito P et al. Antioxidant properties of anesthetics: the biochemist, the surgeon and the anesthetist. Clin Ter 2008; 159 (6): 463–9.
   PubMed Web of Science ®Google Scholar
• Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth 2010; 2 (3): 161–75.
   PubMedGoogle Scholar
• Mazoti M, Braz M, de Assis G et al. Comparison of inflammatory cytokine profiles in plasma of patients undergoing otorhinological surgery with propofol or isoflurane anesthesia. Inflamm Res 2013; 62 (10): 879–85.
   PubMed Web of Science ®Google Scholar
• Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg 2007; 104 (6): 1334–42.
   PubMed Web of Science ®Google Scholar
• Asimakopoulos G, Kohn A, Stefanou DC, Haskard DO, Landis RC, Taylor KM. Leukocyte integrin expression in patients undergoing cardiopulmonary bypass. Ann Thorac Surg 2000; 69 (4): 1192–7.
   PubMed Web of Science ®Google Scholar
• Wu Q, Purusram G, Wang H et al. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery. Br J Clin Pharmacol 2013; 75 (3): 769–78.
   PubMed Web of Science ®Google Scholar
• Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-inducible factor. EMBO J 2012; 31 (11): 2448–60.
   PubMed Web of Science ®Google Scholar
• Hölscher M, Schäfer K, Krull S et al. Unfavourable consequences of chronic cardiac HIF-1α stabilization. Cardiovasc Res 2012; 94 (1): 77–86.
   PubMed Web of Science ®Google Scholar
• Chen HB, Wang L, Jiang JF. Re-analysis of expression profiles for revealing new potential candidate genes of heart failure. Eur Rev Med Pharmacol Sci 2013, 17 (7): 903–11.
   PubMed Web of Science ®Google Scholar
• Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008; 52 (12): 971–8.
   PubMed Web of Science ®Google Scholar
• Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 1994; 91 (13): 5987–91.
   PubMed Web of Science ®Google Scholar
• Chen YH, Lin SJ, Lin MW et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111 (1): 1–8.
   PubMed Web of Science ®Google Scholar
• Dick P, Schillinger M, Minar E et al. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. Eur J Clin Invest 2005; 35 (12): 731–7.
   PubMed Web of Science ®Google Scholar
• Schmidt R, Tritschler E, Hoetzel A et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 2007; 245 (6): 931–42.
   PubMed Web of Science ®Google Scholar
• Gold MI, Sacks DJ, Grosnoff DB, Herrington CA. Comparison of propofol with thiopental and isoflurane for induction and maintenance of general anesthesia. J Clin Anesth 1989: 1 (4): 272–6.
   PubMedGoogle Scholar
• Zgola K, Kulakowski P, Czepiel A et al. Haemodynamic effects of etomidate, propofol and electrical shock in patients undergoing implantable cardioverter-defibrillator testing. Kardiol Pol 2014; 72 (8): 707–15.
   PubMed Web of Science ®Google Scholar
• Korttila K, Ostman P, Faure E et al. Randomized comparison of recovery after propofol-nitrous oxide versus thiopentone-isoflurane-nitrous oxide anaesthesia in patients undergoing ambulatory surgery. Acta Anaesthesiol Scand 1990; 34 (5): 400–3.
   PubMed Web of Science ®Google Scholar
• Jeong CW, Ju J, Lee DW, Lee SH, Yoon MH. Lipid-emulsion propofol less attenuates the regulation of body temperature than micro-emulsion propofol or sevoflurane in the elderly. Yonsei Med J 2012; 53 (1): 198–203.
   PubMed Web of Science ®Google Scholar
• Liu TC. Influence of propofol, isoflurane and enflurance on levels of serum interleukin-8 and interleukin-10 in cancer patients. Asian Pac J Cancer Prev 2014; 15 (16): 6703–7.
   PubMedGoogle Scholar
• Yoo YC, Shim JK, Song Y, Yang SY, Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int 2014; 86 (2): 414–22.
   PubMed Web of Science ®Google Scholar
• Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care 2008; 36 (1): 74–8.
   PubMed Web of Science ®Google Scholar
• Corcoran TB, Engel A, Sakamoto H, O'Shea A, O'Callaghan-Enright S, Shorten GD. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 2006; 97 (6): 825–31.
   PubMed Web of Science ®Google Scholar
• Baki ED, Aldemir M, Kokulu S et al. Comparison of the effects of desflurane and propofol anaesthesia on the inflammatory response and s100 protein during coronary artery bypass grafting. Inflammation 2013; 36 (6): 1327–33.
   PubMed Web of Science ®Google Scholar
• Hambsch J, Osmancik P, Bocsi J, Schneider P, Tárnok A. Neutrophil adhesion molecule expression and serum concentration of soluble adhesion molecules during and after pediatric cardiovascular surgery with or without cardiopulmonary bypass. Anesthesiology 2002; 96 (5): 1078–85.
   PubMed Web of Science ®Google Scholar
• Pa nik J, Baj Z, Moll JA et al. Effects of cardiopulmonary bypass on the expression of adhesive molecules in children undergoing cardiac surgery due to congenital heart disorders. Kardiol Pol 2004; 60 (2): 123–31. Discussion 132.
   PubMedGoogle Scholar
• Tanaka T, Takabuchi S, Nishi K et al. The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages. J Anesth 2010; 24 (1): 54–60.
   PubMed Web of Science ®Google Scholar
• Yeh CH, Cho W, So EC et al. Propofol inhibits lipopoly-saccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. Br J Anaesth 2011; 106 (4): 590–9.
   PubMed Web of Science ®Google Scholar
• Idriss NK, Lip GY, Balakrishnan B, Jaumdally R, Boos CJ, Blann AD. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb Haemost 2010; 104 (5): 1029–37.
   PubMed Web of Science ®Google Scholar
• Zheng H, Ma HP Wang J, Ma M. Preoperative HO-1 levels as prognostic factor for adverse cardiac events in elder patients undergoing non-cardiac surgery. PLoS One 2013; 8 (3): e58567.
   PubMed Web of Science ®Google Scholar
• Hoetzel A, Schmidt R. Regulatory role of anesthetics on heme-oxygenase-1. Curr Drug Targets 2010; 11 (12): 1495–503.
   PubMed Web of Science ®Google Scholar
• Xia WF, Liu Y, Zhou QS, Tang QZ, Zou HD. Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery. Yonsei Med J 2011; 52 (2): 326–32.
   PubMed Web of Science ®Google Scholar
• Gu J, Chi M, Sun X et al. Propofol-induced protection of SH-SY5Y cells against hydrogen peroxide is associated with the HO-1 via the ERK pathway. Int J Med Sci 2013; 10 (5): 599–606.
   PubMed Web of Science ®Google Scholar
• Xu J, Li H, Irwin MG et al. Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats. Crit Care Med 2014; 42 (8): e583–94.
   PubMed Web of Science ®Google Scholar